PMID: 25772181Mar 17, 2015Paper

Adiponectin as a Target in Obesity-related Inflammatory State

Endocrine, Metabolic & Immune Disorders Drug Targets
Koji OhashiNoriyuki Ouchi

Abstract

Accumulating evidence indicates that low grade inflammation is closely associated with obesity-related disorders including type 2 diabetes, hypertension and atherosclerosis. Adiponectin is a fat-derived plasma protein with anti-inflammatory functions. Circulating levels of adiponectin are decreased in obese states, and these conditions are broadly associated with various obesity-related diseases. Furthermore, adiponectin has direct protective functions against cardiovascular disease, cerebrovascular disease, non-alcoholic steatohepatitis (NASH) and chronic kidney disease (CKD). In this review, we will focus on the protective functions of adiponectin against these obesity-related diseases from the view point of its anti-inflammatory properties.

Citations

Sep 11, 2019·Archives of Physiology and Biochemistry·Ahmed M ElghazyMagdy M Youssef
Sep 4, 2015·Molecular Nutrition & Food Research·Vasso ApostolopoulosBarbora de Courten
Apr 6, 2016·Molecular Psychiatry·R Machado-VieiraC A Zarate
Apr 21, 2016·American Journal of Reproductive Immunology : AJRI·Chuan-Mei QinYi Lin
Mar 16, 2016·Neural Plasticity·Vanja DuricLi-Lian Yuan
Jul 27, 2018·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Martina PlatzerEva Z Reininghaus
Nov 9, 2017·The Journal of Endocrinology·Gulizar Issa Ameen, Silvia Mora
Jan 30, 2019·Frontiers in Neuroscience·Leticia Forny-GermanoMarcelo Nunes do Nascimento Vieira
Dec 22, 2017·PloS One·Pasquale De FranciscisMaria Rosaria Rizzo
Aug 28, 2018·Cellular Immunology·Yueshui ZhaoJing Shen
Aug 15, 2021·Advances in Surgery·Amanda MuellerJonathan Carter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Related Papers

Trends in Endocrinology and Metabolism : TEM
Koji OhashiNoriyuki Ouchi
Ryōikibetsu shōkōgun shirīzu
H Ishii, K Okuyama
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Toshiji Saibara, Saburo Onishi
Hepatology Research : the Official Journal of the Japan Society of Hepatology
Goshi Shiota
© 2021 Meta ULC. All rights reserved